Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How do we mention S&L Warrant conversion issue in the letter?

Seems to me the only "fact" we need to know is whether there remain ANY outstanding warrants.  Exact numbers, realtime, will not be known.  The facts you suggest (per the upcoming 10Q) will be some 7 weeks old - so not real-time facts, but historical facts.  So yes, if the 10Q says there are zero outstanding warrants, there is no reason to bring this up.

However, suggesting some reasonable prohibitions on S&L selling their massive shares would still be worthy, IMO.  And declare those prohibitions.  Talk about a great PR item - what if they set a prohibition such that S&L will not sell any shares until the PPS hits $5, and then not more than 10% until the PPS hits $10?  This would establish an expectation by those in-the-know.  It would also provide a level of "comfort" for current and future investors.  As it is, even after the warrants are gone, we still have an entity holding 10% of our OS.  If they act to reduce, we suffer. If they hold, we have a much better opportunity to prosper, IMO.

These things I'm pretty sure of.

SGE

Share
New Message
Please login to post a reply